CHGCY
Price
$22.25
Change
+$0.06 (+0.27%)
Updated
Sep 5 closing price
Capitalization
73.56B
DSKYF
Price
$23.61
Change
-$0.47 (-1.95%)
Updated
Sep 5 closing price
Capitalization
45.57B
Interact to see
Advertisement

CHGCY vs DSKYF

Header iconCHGCY vs DSKYF Comparison
Open Charts CHGCY vs DSKYFBanner chart's image
Chugai Pharmaceutical
Price$22.25
Change+$0.06 (+0.27%)
Volume$120.49K
Capitalization73.56B
Daiichi Sankyo
Price$23.61
Change-$0.47 (-1.95%)
Volume$5.97K
Capitalization45.57B
CHGCY vs DSKYF Comparison Chart in %
Loading...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHGCY vs. DSKYF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHGCY is a StrongBuy and DSKYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CHGCY: $22.25 vs. DSKYF: $23.61)
Brand notoriety: CHGCY and DSKYF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHGCY: 41% vs. DSKYF: 23%
Market capitalization -- CHGCY: $73.56B vs. DSKYF: $45.57B
CHGCY [@Pharmaceuticals: Major] is valued at $73.56B. DSKYF’s [@Pharmaceuticals: Major] market capitalization is $45.57B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHGCY’s FA Score shows that 1 FA rating(s) are green whileDSKYF’s FA Score has 1 green FA rating(s).

  • CHGCY’s FA Score: 1 green, 4 red.
  • DSKYF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CHGCY and DSKYF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHGCY’s TA Score shows that 5 TA indicator(s) are bullish while DSKYF’s TA Score has 3 bullish TA indicator(s).

  • CHGCY’s TA Score: 5 bullish, 3 bearish.
  • DSKYF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CHGCY is a better buy in the short-term than DSKYF.

Price Growth

CHGCY (@Pharmaceuticals: Major) experienced а +1.64% price change this week, while DSKYF (@Pharmaceuticals: Major) price change was +0.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.16%. For the same industry, the average monthly price growth was +3.97%, and the average quarterly price growth was +10.41%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCY($73.6B) has a higher market cap than DSKYF($45.6B). CHGCY has higher P/E ratio than DSKYF: CHGCY (27.41) vs DSKYF (22.42). CHGCY YTD gains are higher at: 1.274 vs. DSKYF (-11.241). CHGCY has higher annual earnings (EBITDA): 556B vs. DSKYF (405B). CHGCY has more cash in the bank: 1.03T vs. DSKYF (848B). DSKYF has higher revenues than CHGCY: DSKYF (1.76T) vs CHGCY (1.2T).
CHGCYDSKYFCHGCY / DSKYF
Capitalization73.6B45.6B161%
EBITDA556B405B137%
Gain YTD1.274-11.241-11%
P/E Ratio27.4122.42122%
Revenue1.2T1.76T68%
Total Cash1.03T848B121%
Total DebtN/A102B-
FUNDAMENTALS RATINGS
CHGCY vs DSKYF: Fundamental Ratings
CHGCY
DSKYF
OUTLOOK RATING
1..100
112
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
85
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
993
PRICE GROWTH RATING
1..100
8163
P/E GROWTH RATING
1..100
6695
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHGCY's Valuation (26) in the null industry is somewhat better than the same rating for DSKYF (85). This means that CHGCY’s stock grew somewhat faster than DSKYF’s over the last 12 months.

CHGCY's Profit vs Risk Rating (94) in the null industry is in the same range as DSKYF (100). This means that CHGCY’s stock grew similarly to DSKYF’s over the last 12 months.

DSKYF's SMR Rating (3) in the null industry is significantly better than the same rating for CHGCY (99). This means that DSKYF’s stock grew significantly faster than CHGCY’s over the last 12 months.

DSKYF's Price Growth Rating (63) in the null industry is in the same range as CHGCY (81). This means that DSKYF’s stock grew similarly to CHGCY’s over the last 12 months.

CHGCY's P/E Growth Rating (66) in the null industry is in the same range as DSKYF (95). This means that CHGCY’s stock grew similarly to DSKYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHGCYDSKYF
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GEVO1.670.04
+2.45%
Gevo
PRCH18.200.25
+1.39%
Porch Group
BZFD1.860.01
+0.54%
BuzzFeed Inc.
OKLO69.790.18
+0.26%
Oklo Inc.
CYCCP4.80-0.04
-0.90%
Cyclacel Pharmaceuticals

CHGCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHGCY has been loosely correlated with DSNKY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHGCY jumps, then DSNKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
+0.27%
DSNKY - CHGCY
38%
Loosely correlated
-1.06%
OTSKY - CHGCY
32%
Poorly correlated
+2.67%
OPHLY - CHGCY
32%
Poorly correlated
+0.52%
CHGCF - CHGCY
28%
Poorly correlated
+9.42%
DSKYF - CHGCY
23%
Poorly correlated
-1.93%
More

DSKYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSKYF has been loosely correlated with DSNKY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DSKYF jumps, then DSNKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSKYF
1D Price
Change %
DSKYF100%
-1.93%
DSNKY - DSKYF
34%
Loosely correlated
-1.06%
CHGCY - DSKYF
23%
Poorly correlated
+0.27%
CHGCF - DSKYF
13%
Poorly correlated
+9.42%
CHJTF - DSKYF
7%
Poorly correlated
N/A
CSPCY - DSKYF
5%
Poorly correlated
+1.24%
More